The reduced serum adiponectin level in NASH mice led us to speculate about the involvement of adiponectin in the pathogenesis of exacerbated skin inflammation in IMQ-treated STAM mice. Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.